MedTrace Logo

A Cross-sectional Study Evaluating Pregnancy Related Use of Vitamins and Medication

NCT03105583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 381

Last updated 2019-01-29

No results posted yet for this study

Summary

This cross-sectional study will try to give answers to the following project aims:

* To provide an overview of the prevalence of health products' use among Belgian pregnant women (prescription and OTC medication, vitamin supplements, phyto-therapeutics, dermatologic products), including where pregnant women buy or get their health products (online web survey).
* To document women's beliefs about medication during pregnancy and their information desire (online web survey).
* To determine the current vitamin status among pregnant women and to reveal clinical targets for supplementing deficiencies in this population (blood sample analysis).

The study will be performed at the obstetrics department of the University Hospitals of Leuven (campus Gasthuisberg).

We aim to include 300 pregnant women (100 per trimester), of which 150 women will be asked to determine their vitamin status (50 per trimester).

Conditions

  • Medication and Supplement Use
  • Pregnant Women

Interventions

DRUG

Medication use during pregnancy

DIETARY_SUPPLEMENT

Supplement use during pregnancy

OTHER

Vitamin status of a pregnant woman

Haemoglobin, RBC count + hematocrits, thrombocytes count, folate (serum), vitamin B12, WBC count, ferritin, iron (serum), transferrin % and saturation, TSH, T4, free glucose, LDH, ALT, AST, GGT, bilirubin (total), CRP, albumin, total protein, ureum, uric acid, creating, calcium (total), 25-hydroxy vitamin D, Na, K, Mg

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER

  • KU Leuven

    lead OTHER

Principal Investigators

  • Veerle Foulon, PhD, PharmD · KU Leuven

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-04-30
Completion
2018-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03105583 on ClinicalTrials.gov